Thomas Gad - 20 Jan 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Signature
/s/ THOMAS GAD
Issuer symbol
YMAB
Transactions as of
20 Jan 2022
Transactions value $
-$2,033,105
Form type
4
Filing time
24 Jan 2022, 16:39:09 UTC
Previous filing
20 Jan 2022
Next filing
26 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$1.28M -113K -9% $11.33 1.14M 20 Jan 2022 By GAD Enterprises LLC F1, F2, F3
transaction YMAB Common Stock Sale -$527K -50.1K -4.39% $10.51 1.09M 21 Jan 2022 By GAD Enterprises LLC F1, F3, F4
transaction YMAB Common Stock Sale -$229K -20.2K -1.85% $11.35 1.07M 21 Jan 2022 By GAD Enterprises LLC F1, F3, F5
holding YMAB Common Stock 50K 20 Jan 2022 Direct
holding YMAB Common Stock 60K 20 Jan 2022 By Children F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by lender pursuant to a forced sale of common stock pledged to secure a margin loan pursuant to an agreement with the lender following a margin call on the common stock securing the margin loan.
F2 This transaction was executed in multiple trades at prices ranging from $10.88 to $11.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Reporting Person is sole member of GAD Enterprises, LLC and the sole member and manager of GAD Management, LLC, the manager of GAD Enterprises, LLC, and as such Reporting Person has sole voting and dispositive power with respect to such shares.
F4 This transaction was executed in multiple trades at prices ranging from $10.06 to $11.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $11.06 to $11.49. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 Represents shares owned by Reporting Person's children who are deemed to share Reporting Person's household.

Remarks:

Chairman, President and Head of Business Development & Strategy